COVID-19: WHO resumes study on Hydroxychloroquine

0
73
WHO bans the use of coronavirus vaccine

On June 3, the World Health Organization (WHO) resumed a study looking into whether the malaria drug hydroxychloroquine could be effective in treating COVID-19.

According to reports, the World Health Organization has once again declared hydroxychloroquine useful for the treatment of corona.

According to sources, chloroquine was tested on patients in 400 hospitals among 35 countries.

Earlier, the World Health Organization (WHO) said there was no evidence that hydroxychloroquine could benefit coronavirus patients.

Some experts believe the drug might help control COVID-19 in part by blocking the virus’ ability to bind to the body’s cells.

Studies in animals and cell cultures in the lab show it may also help suppress the aggressive immune reaction that doctors have seen in some patients’ lungs and respiratory systems. That suggests that by the time a COVID-19 patient is hospitalized, it might be too late for hydroxychloroquine to help, since the infection is already well underway.

But until doctors have the results of rigorous trials that randomly assign hospitalized patients to receive hydroxychloroquine or placebo—like the ones currently conducted under the guidance of the NIH and WHO—are completed, they won’t know for sure if that’s the case.

During a press conference, officials said they would continue to gather evidence about the efficacy and safe use of hydroxychloroquine, however, have stopped using it to treat the coronavirus patients.

Stay tuned to Baaghi TV for further updates!

What is chloroquine and could it cure the coronavirus? 

Leave a reply

More News